| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |